论文部分内容阅读
目的:观察呼吸内科规范治疗慢性支气管炎的效果作用。方法:选取2014年7月至2015年7月期间于我院行慢性支气管炎治疗的54例患者作为研究对象,并根据不同治疗方式分为对照组和治疗组,每组27例,其中对照组行常规治疗方法,治疗组行呼吸内科规范治疗,对比两组患者的治疗效果以及不良反应发生情况。结果:治疗后,治疗组的总有效率(96.30%)显著高于对照组(74.07%),且P<0.05;治疗组的不良反应率(3.70%)明显低于对照组(22.22%),且P<0.05。结论:在慢性支气管炎中应用呼吸内科规范治疗具有显著的治疗效果,有利于患者更及时地恢复健康,值得临床推广。
Objective: To observe the effect of respiratory medicine standard treatment of chronic bronchitis. Methods: Fifty-four patients with chronic bronchitis treated in our hospital from July 2014 to July 2015 were selected as study subjects and divided into control group and treatment group according to different treatment methods, with 27 cases in each group. The control group Routine treatment, the treatment group, Department of Respiratory Medicine standardized treatment, the treatment of patients compared two groups and the incidence of adverse reactions. Results: After treatment, the total effective rate (96.30%) in the treatment group was significantly higher than that in the control group (74.07%), P <0.05. The adverse reaction rate in the treatment group was significantly lower than that in the control group (3.70% vs. 22.22% And P <0.05. Conclusion: The application of respiratory medicine in the treatment of chronic bronchitis has a significant therapeutic effect, is conducive to patients recover more timely and worthy of clinical promotion.